ANTIPLATELET ACTIVITY TO HIGH LOADING DOSE OF CLOPIDOGREL IS SIMILAR IN DIABETIC VERSUS NON-DIABETIC PATIENTS QUANTIFIED USING A NOVEL POINT-OF-CARE PLATELET AGGREGATION.

Autor: Nathan, S., Kumar, A., Dallow, Al R., Amin, A., Kelly, R. F., Klein, L. W., Calvin, J. E., Bakris, G. L.
Zdroj: Journal of Investigative Medicine (Sage Publications Inc.); Mar2005, Vol. 53 Issue 2, pS400-S401, 2p
Databáze: Complementary Index